Internal Medicine, Endocrinology, Diabetes, & Metabolism · Greenville, NC
NPI
1841606308
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1006 Wh Smith Blvd
Greenville, NC, 27834
Phone (252) 413-6683
Groups this clinician bills Medicare through
Medicare paid, 2024
$798K
44,553 services
Medicare patients, 2024
960
Average age 73
Drug cost, 2024
$4.1M
8,498 prescriptions
Company payments, 2025
$1,060
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew R Hager was code J0897 (injection, denosumab, 1 mg), 7,744 times for 76 patients. In total Matthew R Hager billed 44,553 services in 89 codes, and Medicare paid $798K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,744 | 76 | $20.65 | $160K |
| 99214 Office E&M - Established | Office | 1,206 | 642 | $89.83 | $108K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 683 | 474 | $12.10 | $8,262 |
| 99457 E&M - Miscellaneous | Office | 571 | 129 | $35.83 | $20K |
| 36415 Venipuncture Blood Collection | Office | 557 | 401 | $8.65 | $4,818 |
| 83036 Blood Count | Office | 555 | 309 | $9.48 | $5,259 |
| 82962 Clinical Chemistry | Office | 494 | 287 | $3.20 | $1,583 |
| 84443 Clinical Chemistry | Office | 422 | 311 | $16.46 | $6,946 |
| 84439 Clinical Chemistry | Office | 365 | 266 | $8.84 | $3,227 |
| 95251 Test - Miscellaneous | Office | 318 | 166 | $25.52 | $8,114 |
| 99458 E&M - Miscellaneous | Office | 279 | 100 | $28.61 | $7,983 |
| 77080 Standard X-ray | Office | 225 | 225 | $19.23 | $4,327 |
| 96372 Injection Administration | Office | 187 | 89 | $10.26 | $1,918 |
| 80053 Clinical Chemistry | Office | 172 | 159 | $10.35 | $1,780 |
| 76536 Ultrasound - Nonspecific | Office | 150 | 148 | $57.40 | $8,610 |
By year: 2022 $537K for 39,623 services; 2023 $722K for 49,263 services; 2024 $798K for 44,553 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 557 | 401 | $8.65 | $4,818 |
| 83036 Blood Count | 555 | 309 | $9.48 | $5,259 |
| 82962 Clinical Chemistry | 494 | 287 | $3.20 | $1,583 |
| 84443 Clinical Chemistry | 422 | 311 | $16.46 | $6,946 |
| 84439 Clinical Chemistry | 365 | 266 | $8.84 | $3,227 |
| 80053 Clinical Chemistry | 172 | 159 | $10.35 | $1,780 |
| 85025 Blood Count | 116 | 109 | $7.61 | $883 |
| 80061 Clinical Chemistry | 113 | 104 | $13.12 | $1,483 |
| 84481 Clinical Chemistry | 101 | 78 | $16.60 | $1,677 |
| 82306 Clinical Chemistry | 83 | 80 | $29.01 | $2,408 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew R Hager prescribed most often to Medicare patients was Ozempic (Semaglutide), with 997 prescriptions and refills. In total Matthew R Hager wrote 8,498 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 997 | 1,302 | 179 | $1.2M |
| Levothyroxine Sodium Generic | 852 | 1,956 | 203 | $8,298 |
| Glipizide Er Glipizide | 371 | 767 | 97 | $4,675 |
| Metformin Hcl Er Metformin Hcl | 369 | 815 | 102 | $3,789 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 265 | 362 | 62 | $236K |
| Methimazole Generic | 234 | 452 | 53 | $2,048 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 233 | 342 | 47 | $172K |
| Tresiba Flextouch U-100 Insulin Degludec | 223 | 380 | 67 | $157K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 223 | 281 | 45 | $86K |
| Synthroid Levothyroxine Sodium | 187 | 353 | 41 | $14K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 182 | 268 | 33 | $145K |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 178 | 226 | 41 | $83K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 170 | 374 | 63 | $14K |
| Glipizide Generic | 169 | 354 | 50 | $1,284 |
| Mounjaro Tirzepatide | 168 | 207 | 32 | $209K |
Brand drugs: 4,910 claims; generic drugs: 2,998 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew R Hager $1,060 ($1,060 in general payments such as food, travel and fees) from 20 companies. The largest payer was Sequel Med Tech, LLC with $201.
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 2 | $201 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $175 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $89.98 |
| Corcept Therapeutics CORT | 3 | $67.34 |
| Averitas Pharma Inc. | 2 | $65.08 |
| Beta Bionics, Inc. BBNX | 2 | $63.75 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $57.88 |
| Radius Health, Inc. | 2 | $44.97 |
| Novo Nordisk Inc NVO | 2 | $43.43 |
| Mannkind Corporation MNKD | 1 | $42.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.